Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: A pilot study

Thorax

Volumn 59, Issue 8, 2004, Pages 699-703

  Conway, S P ^a,b   Oldroyd, B ^b   Morton, A ^b   Truscott, J G ^b   Peckham, D G ^b  

^a SEACROFT HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ETIDRONIC ACID; PAMIDRONIC ACID; PHOSPHATE; SANDOCAL; VITAMIN D;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ESOPHAGUS DISEASE; FEMALE; FEMUR NECK; HEARTBURN; HUMAN; HYPOGONADISM; LUMBAR SPINE; MALE; NAUSEA; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; QUESTIONNAIRE; THYROID DISEASE; THYROID FUNCTION; VOMITING;

ADMINISTRATION, ORAL; ADULT; BODY COMPOSITION; BONE DENSITY; BONE DISEASES, METABOLIC; CYSTIC FIBROSIS; DENSITOMETRY, X-RAY; DIPHOSPHONATES; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 4043135088     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2002.002568     Document Type: Article

References (28)

1. Henderson RC, Madsen CD. Bone mineral content and body composition in children and young adults with cystic fibrosis. Pediatr Pulmonol 1999;27:80-4.
2. Haworth CS, Selby PL, Webb AK, et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999;54:961-7.
3. Conway SP, Morton AM, Oldroyd B, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000;55:798-804.
4. Aris RM, Stephens AR, Ontjes DA, et al. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 2000;162:1674-8.
5. Ionescu AA, Nixon LS, Evans WD, et al. Bone density, body composition and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000;162:789-94.
6. Henderson RC, Specter BB. Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr 1994;125:208-12.
7. Aris RM, Renner JB, Winders AD, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998;128:186-93.
8. Aris RM, Neuringer IP, Weiner MA. Severe osteoporosis before and after lung transplantation. Chest 1996;109:1176-83.
9. Donovan DS, Papadopoulos A, Staron RB, et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 1998;157:1892-9.
10. Baroncelli GI, de Luca F, Magazzu G, et al. Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res 1997;41:397-403.
11. Haworth CS, Webb AK, Egan JJ, et al. Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000;118:434-9.
12. Cranney A, Guyatto G, Krolick N, et al. A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. Osteoporosis Int 2001;12:140-51.
13. Homik J, Cranney A, Shea B, et al. Bisphosphonate for steroid induced osteoporosis (Cochrane Revew). In: The Cochrane Library. Issue 2. Chichester, UK: John Wiley & Sons, 2001.
14. Truscott JG, Oldroyd B, Simpson M, et al. Variation in lumbar spine and femoral neck bone mineral measured by duol energy x-ray absorption: a study of 329 women. Br J Radiol 1993;66:514-21.
15. Woodrow G, Oldroyd B, Turney JH, et al. Influence of changes in peritoneal fluid on body composition measurements by dual-energy x-ray absorpitiometry in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1996;64:237-41.
16. Oldroyd B, Milner R, Smith AH, et al. A total body phantom for use with lunar dual-energy X-ray absorptiometers. Appl Radiat Isot 1998;49:525-6.
17. Cruz DN, Brickel HM, Wysolmerski JJ, et al. Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate. Am J Transpl 2002;2:62-7.
18. Sood M, Hambleton G, Super M, et al. Bone status in cystic fibrosis. Arch Dis Child 2001;84:516-20.
19. Hordin DS, Arumugam R, Seilheimer DK, et al. Normal bone density in cystic fibrosis. Arch Dis Child 2001;84:363-8.
20. Haworth CS, Selby PL, Horrocks AW, et al. A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax 2002;57:719-23.
21. Manalogas SC. Birth and death of bone cells: bosic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115-37.
22. Reinholz GG, Getz B, Pederson L, et al. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 2000;60:6001-7.
23. Haworth CS, Selby PL, Adams JE, et al. Effect of intravenous pomidronate on bone mineral density in adults with cystic fibrosis. Thorax 2001;56:314-6.
24. Aris RM, Lester GE, Renner JB. Efficacy of pamidronote for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000;162:941-6.
25. Tothill P, Pye DW. Errors due to non-uniform distribution of fat in dual x-ray absorptiometry of the lumbar spine. Br J Radiol 1992;65:807-13.
26. Peel NFA, Eastell R. Comparison of rates of bone loss from the spine measured using two manufacturers' densitometers. J Bone Min Res 1995;10:1796-801.
27. Tothill P, Avenell A. Anomalies in the measurement of changes in bone mineral density of the spine by dual-energy x-ray absorptiometry. Calcif Tissue Int 1998;63:126-33.
28. Tothill P, Laskey MA, Orphanidou CI, et al. Anomalies in dual energy x-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. Br J Radiol 1999;72:661-9.